Bright Minds Biosciences
DRUG
#6700
Rank
NZ$1.17 B
Marketcap
NZ$151.31
Share price
-3.62%
Change (1 day)
117.63%
Change (1 year)

Market capitalization of Bright Minds Biosciences (DRUG)

Market cap: NZ$1.17 Billion

As of January 2026 Bright Minds Biosciences has a market cap of NZ$1.17 Billion. This makes Bright Minds Biosciences the world's 6700th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bright Minds Biosciences from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.17 B6.71%
2025NZ$1.10 B138.55%
2024NZ$0.46 B3993.29%
2023NZ$11.3 M-49%
2022NZ$22.17 M-60.05%
2021NZ$55.5 M

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of Bright Minds Biosciences was reported to be:

NZ$1.15 Billion
by Nasdaq info icon info icon
NZ$1.17 Billion
by CompaniesMarketCap info icon info icon